Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma
Programmed cell death 1 (PD-1) inhibitor therapy for lung adenocarcinoma may induce rare but severe hematologic adverse events, including severe anemia. Although glucocorticoids are recommended for managing immune-related adverse events, therapeutic experience with PD-1 inhibitor-induced severe anem...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Chinese |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2025-06-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2025.102.25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|